Anticarcinogenic effects of miR-199a-loaded gold nanoparticles on hepatocellular carcinoma: in vitro study

Samar El Achy1,2, Maisa E Moustafa3, Mohamed Fouad2,4

  • 1Department of Pathology, Faculty of Medicine, Alexandria University, Alexandria, 21521, Egypt.

Scientific Reports
|April 2, 2026
PubMed

Insights

Gold nanoparticles effectively deliver microRNA-199a to liver cancer cells, significantly increasing cancer cell death. This targeted delivery system shows promise for developing novel hepatocellular carcinoma (HCC) therapeutics.

Area of Science:

  • Oncology
  • Nanotechnology
  • Molecular Biology

Background:

  • Hepatocellular carcinoma (HCC) presents a significant oncological challenge requiring novel therapeutic strategies.
  • MicroRNAs (miRNAs) are crucial regulators of cancer development, influencing cell proliferation and apoptosis.
  • Efficient delivery of therapeutic miRNAs to tumor sites remains a major hurdle in cancer treatment.

Purpose of the Study:

  • To develop and evaluate gold nanoparticles (Au NPs) as a delivery vehicle for miRNA in HCC treatment.
  • To investigate the efficacy of surface-modified Au NPs loaded with miR-199a for targeting and treating HCC cells.

Main Methods:

  • Gold nanoparticles (Au NPs) were synthesized and functionalized with polyethylene glycol (PEG) for miRNA attachment.
  • The modified Au NPs were loaded with miR-199a to create a nanocomplex.
  • Cytotoxicity assays were performed on HCC cells treated with bare Au NPs and the miRNA-PEG-Au NP nanocomplex.

Main Results:

  • Bare Au NPs exhibited low cytotoxicity (11.11% ± 2.25%) at 80 nM.
  • The miRNA-PEG-Au NP nanocomplex demonstrated significantly increased cellular cytotoxicity (55.7% ± 4.55%) at 80 nM.
  • The nanocomplex suppressed tumor cell proliferation and enhanced apoptosis in a concentration- and time-dependent manner.

Conclusions:

  • Surface-modified Au NPs serve as effective carriers for miRNA delivery in HCC.
  • This targeted nanomaterial-based miRNA delivery system enhances cellular uptake and exerts a potent anticancer effect on HCC cells.
  • The findings suggest a promising new approach for precision therapeutics in hepatocellular carcinoma management.